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Abst rac t  
In exploring the occurrence and mechanism of liposome-encapsalated hemoglobiri (LEH)Anduced cc, mplcmem (CI 
acti'~,'ation, wefeund thai normal human sernm contained Imv tilers t~f IgG atld lgM class natural antibodies wilh reactivity 
ugainsl LEH, and that the amoum of ~esicle-bound IgM significantly correlated wilh LEH-induced C consumption. IgM 
binding to LEH was inhibited by phospbocholine and ATP. but not by cholifte chloride. These data surest Ihat naturally 
occurring antibodies play a key role in LEtt induced C :~ctivati,:,n. a d that a major portion of these antibodies are directed 
against he phosphate moiety on the phospholipid headgroups of liposome bilayers. 
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Liposome-encapsulatcd hemoglobin (LEH) repre- 
sents a potential oxygen carrier blood substitute with 
a unique capability to imitate the hemoglobin (Hb) 
Oz-transport function of etythrocytes without risk for 
immune hemolytic reactions due to mismatched 
transfusion [ I -4].  While the efficacy of LEH to 
provide life support has been demonstrated in exsan- 
guinated rats [1.5]. freedom from acute immune ef- 
fects may not be complete. LEH has been shown to 
cause complement (C') activation in r~ts [6.7], which 
effect was suggested to underlie the transient cardio- 
vascular, hematological and respiratory changes re- 
ported in this species following intravenous injection 
of this blood substitute [8--II], 
In extending these studies to humans, we have 
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found that incubation of LEH with normal human 
serum alsu induces C activation, as indicated by C 
consumption with associated elevation of C split 
products: C5a, SC5b-9, C4cl and Bb [12]. We ob- 
tained indications for the involvement of both the 
classical (CP) and alternative pathways (APt in 
LEH-induced C activation [12], however, that infor- 
mation cannot be regarded as conclusive with regard 
to the possible role of antibodies in the activation 
chain, as there are examples rot CP activation of C 
through antibody-independent [ 13-16]. as well as AP 
activation by antibody-mediated [ 17,18] processes. 
An earlier study from our laboratory presented 
evidence that naturally occurring anti-cholesterol an- 
tibodies played a key role in the liposome-induced 
severe anaphylactoid reaction of pigs [19]. Yet. de- 
spite detailed investigations on the interaction of 
liposomes with plasma proteins [20.21] and extensive 
literaturc on liposome-induccd C activation [13 
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16.22--25]. the role of natural antibodies in 
liposome-induced C activation has not gained wide 
awareness to-date, 
In the present study we have tbcused therefore on 
the role of antibodies in LEH-induced C activation. 
In particular, we wished to explore the presence of 
munra] antibodies in human serum with reactivity to 
LEH, the class of these antibodies, their tiler, speci- 
ficity and rule in LEH-induced C activation. 
The preparati(m of LEH from distearoylphos- 
phatidylcholine, dimyristoylphosphatidylglycerok 
cholesterol and a-toeopherol (50:4.5:45:0.5 mole ra- 
tio, obtained fi'om Avanti Polar Lipids, Alabaster. 
AL). using a microfluidizcr, was described earlier 
[2.6.11.12,26]. For the present study we used a small 
unihtmelhu, highly homodisperse preparation, which 
was obtained by comract from Vestar (San Dbnas, 
CA. now called Nexstar) and was prepared as de- 
scribed earlier [12]. In brief, human serum albumin 
(HSA) was coencapsulaled with heat-sterilized, 
bis(3.5-dibromosalicyl)fumarate (diaspirin)-cross- 
linked human Hb (ce~ Hb) [27]. the homogenization 
step was performed in a Gaulin homogenizer, unen- 
capsulated protein was removed by tangential flow 
filtration, and the final product, containing 20 mg/ml  
o:o~ Hb and 6 mg/ml  HSA, was subjected to filtration 
through 0.45 /zm pore size polycarbonate filters. 
Dynamic light scattering showed the mean vesicle 
diameter to be 186-I-82 nm with narrow unimodal 
size disn'ib~tion (i.e. 100% in main peak). Control 
liposomes containing HSA were prepared identically. 
except that net Hb was omitted. 
Details of the solid-phase ELISA developed to 
detect lipid specific antibodies were described earlier 
[28,29]. In brieL wells of 96-well Costar plates were 
coated with LEH (25 nmol phospholipid/50/zl PBS), 
blocked with 100 #1 of 0.3% gelatin in PBS, washed 
with PBS and incubated with 50 p,I seruln at various 
dilutions for 4 h at room temperature. Phttes were 
washed with PBS and the amount of LEH-bound 
antibody was measured using affinity-purified. 
horseradish peroxidase-conjugated auti-huntan lgG 
(y-chain) or aati-hmnan lgM (/z-chain) antibodies 
(Binding Site, Birmingham, UK) at 500-fold dilution. 
Values were corrected for background, i.e., A4~5 
readings obtained ill uncoated wells. 
Binding of natural!y occurring IgM to LEH in the 
presettce of phusphocholine chloride, choline chloride 
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and ATP (the latter compounds obtained from Sigma. 
Me)  was measured in a similar assay, except that 
only one serum dilution (80-fold) was used, and the 
samples were spiked with the indicated amounts of 
inhibitors, or were diluted with an equivalent volume 
of PBS. To quantitate the amount of LEH-bound 
antibodies following incubation with undiluted serum, 
similar IELISA was carried out as above, except that 
LEH was first incubated with serum and was washed 
in PBS (three times) before being used to coat the 
wells of microtiter plates. 
Human blood was obtained from healthy volun- 
teers by a protocol approved by the Walter Reed 
Army Medical Center Human Use Committee. It was 
allowed to clot at room temperature and the serum 
was stored at -80°(2 before incubation with LEH (1 
h at 37~C with shaking) at a LEH to serum volume 
ratio of 1:5 (20 ram LEH phospholipid). After incu- 
bation, vesicles were separated from the serum by 
centrifugation and hemolytic C activity was deter- 
mined in the serum by the sheep red cell hemolysis 
assay, as described earlier [6]. 
Fig. 1 shows the titration curves for natural anti- 
LEH IgG and IgM antibodies in a volunt~r's erum, 
as measured by ELISA. End-point dilution factors for 
IgG and lgM, defined as the highest seram dilution 
where A4~5 was still significantly higher than the 
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Fig, I, Taralam of LEH-rcacuive natural I+~G (Or  ~nU IgM tO ) 
antibodies in the serum of a heil[thy xoluntecr. Antibody binding 
to LEH ~,~a~ delermined in stUid phase ELISA, using c~a Hb-con- 
tahl i l lg LEH as antigOl, as described in the Methods. Values are 
nleatls ± S.E.M. t\)r 4 ut 5 wells+ corrected tk+r back~rtnmd (i.¢. 
rot A4t~ in non-co,tied '.vc.llsl. 
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background, were 320 and _> ( 'MO.  respectively. Simi- 
lar measurements in the sere of 8 volumeer individu- 
als (including the one presented above) gave 80 as 
the median of end-point dilution factors for LEH-re- 
active lgG (range: 20 and 320, with no detectable 
antibody binding in 1 serum), and > 640 for IgM in 
8 /8  sera. These data suggest hat most human sere 
contain low tilers of natund lgG and IgM antibodies 
that shows reactivity to LEH, with IgM liters exceed- 
ing those of IgG. 
In order to clarify the specificity of anti-LEH 
antibodies, i.e. whether they are directed against the 
liposome membrane and/or  against membran:'-ex- 
posed Hb and/or  H,qA. we have utilized the fact t~at 
the binding of anti-phospholipid antibodies to lipo- 
somes can be inhibited with organic phosphates (ATP. 
phosphorylcholine chloride), but not by choline chlo- 
ride [30]. The experiment esting the effect of the 
latter compounds on lgM binding to LEH revealed 
significant inhibition by 30 mM ATP and 10 mM 
phosphocholine, but not by 10 mM choline chloride 
(Fig. 2). Hence, u substantial portion of unti-LEH 
antibodies appeared to be phospholipid specific, with 
binding affinity to the phosphate groups on the phos- 
pbolipid head groups of l iposome bilayers [30]. This 
observation is in keeping with the fact that low levels 
of natural antibodies with phospholipid specificity are 
widespread in "all animal species [31]. 
Concerning the role of ami-LEH antibodies in 
LEH-indueed C activation. Fig. 3 shows a significant 
positive correlation between C consumption and the 
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Fig. 2. The elleer of organic phosphate compt,unds un the 
bindin$ of I~M to LEH in the serum of a healthy volunteer The 
effects of In mM phosphochoUne. 3tl mM ATP and II} mM 
choline chhlride on IgM binding to LEH wa~, determined b~. 
ELISA, as in Fig. I. Serum t~om a wdunleer dunor we:, diluted 
SO-told wilh PBS and were spiked with the inhibittlrs or an etlLa' 
volume of PnS (c(mlrol}. Bars are mcans±S.E.M, lor 4 or 5 
wells, corrected t~= background. 
Fig. 3 Correlation between LEH-induced C consumpti~m ,nd the 
biuding of I~lM ,innbtldies to LEH in 12 normal humz:n s,~'ra. 
LEH bound IgM wa~ dete~ined by solid phase ELISA u~ing 
,cram-exposed ~v~ Hb-contaming LEH as antigen, as described. 
Backgrou~tl-conecled ALl ~ Vahlc~ were plolletl agai~l C cola- 
~ttnlpllon. expressed ~, % decrease in CH5n/ml, ~ ,rnp!~mcnl 
ctmslal)ptK~n  estimated by measunng hemolytic (? aelivax :~1 
lilt2 serum, a~ described. Significanl cqwrelation at P = nol (r -: 
I17IlL zls detenllinL'd by regression analy~i~ 
amount of LEH-bound lgM in 12 sera. x~hich nro- 
vides strong indication for a causal relationship be- 
tween C activation and the binding of lgM to the 
",esicles. Such relationship was not observed betweea 
LEH-bound lgG and C consumption (data not shown), 
which difference could be explained by the lower 
efficiency of IgG to complex CIq in cumparison with 
lgM. 
Consistent with a primary role of l iposomal phos- 
pholipids in LEH-induced C activation, previous ex- 
periments [7.12] showed only minor quantitative dif- 
lerences between LEH and empty (PBS-containing) 
liposome-induced C activation. Also, control studies 
indicated that the procedures involved in the prepara- 
tion of LEH (microfluidization, membrane filtration) 
are not responsible for the C activating potency of 
LEH (data not shown). Thus, beyond the implications 
regarding a potential adver:~e effect of LEH as a 
blood substitute, our results contribute to the under- 
standing the interactions of liposomes with the C 
system. In particular, anionic liposomes have been 
shown earlier to activate C through the CP [16]. whlle 
a recent study described that anionic liposomc-in- 
duecd C activation manifested itself at a lower sur- 
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face charge in the presence of  immunog lobu l ins  than 
in their absence [25], These data together  w i th  the 
FrcscBt study suggest that C act ivation by anionic  
l iposomes can be induced b2,. more  than one mecha-  
nism. However ,  once lgM is involved, the eff ic iency 
of  activation may be ampl i f ied,  so that the ant ibody-  
mediated process prevails over  other  mechan isms.  
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